Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

8.05USD
18 Jan 2019
Change (% chg)

$-0.21 (-2.54%)
Prev Close
$8.26
Open
$8.29
Day's High
$8.41
Day's Low
$7.97
Volume
6,623
Avg. Vol
19,655
52-wk High
$19.00
52-wk Low
$5.57

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.66 -0.599
Jun '18 0.46 -0.693
Mar '18 1.15 -0.741
FY 2017 Dec '17 0.99 -1.028
Sep '17 0.60 -0.869
Jun '17 0.25 -0.872
Mar '17 0.14 -0.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 1.00 2.00 0.00 --
Quarter Ending Jun-19 2 1.10 2.20 0.00 --
Year Ending Dec-19 6 9.65 18.60 0.00 --
Earnings (per share)
Quarter Ending Mar-19 3 -0.80 -0.70 -0.91 --
Quarter Ending Jun-19 3 -0.55 0.14 -0.98 --
Year Ending Dec-19 6 -3.35 -2.59 -4.08 --
LT Growth Rate (%) 1 40.40 40.40 40.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta -- 0.66 0.95
Price to Sales (TTM) 43.37 242.95 21.76
Price to Book (MRQ) 1.13 18.87 4.53
Price to Tangible Book (MRQ) 1.13 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 10.22 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago 147.31 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.08 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago -7.23 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 13.01 6.87 3.68
LT Debt to Equity (MRQ) 0.00 16.70 9.53
Total Debt to Equity (MRQ) 0.00 21.89 13.39
Interest Coverage (TTM) -- -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -1,388.21 -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -1,399.51 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -1,375.30 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -1,375.30 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 93,343 28,103,806 878,349,382
Net Income/Employee (TTM) -1,283,743 -3,710,889 102,474,711
Receivable Turnover (TTM) 3.60 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.04 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.59 0.35 11.06
Return on Assets - 5 Yr. Avg. -- 2.90 11.85
Return on Investment (TTM) -59.99 0.60 13.80
Return on Investment - 5 Yr. Avg. -- 2.87 15.17
Return on Equity (TTM) -213.16 -2.18 15.29
Return on Equity - 5 Yr. Avg. -- -0.88 16.29
  1 Year 3 Year 5 Year
Sales % 490.75 -- --
EPS (TTM) % -48.97 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spero Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.77 -4.75 86 99
13 Week -31.24 -25.72 60 94
26 Week -28.20 -28.00 85 96
52 Week -44.63 -46.30 58 98
YTD -33.70 -33.91 76 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 59.83%
# of Holders: 83
Total Shares Held: 10,881,155
3 Mo. Net Change: 2,738,527
# New Positions: 17
# Closed Positions: 5
# Increased Positions: 54
# Reduced Positions: 13
# Net Buyers: 41
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.